Since the COVID-19 pandemic reached the US, increasing concern has been expressed about the politicization of the CDC and FDA due to pressure from the Trump administration to downplay the severity of the pandemic and push out treatments and a vaccine as fast as possible, potentially at the expense of safety. This has led me to a disturbing question: Can I trust the CDC and FDA any more?
Yesterday, the FDA issued emergency use authorization for hydroxychloroqine and chloroquine to treat COVID-19. Politics, not science, is why.
St. Elizabeth Healthcare in Cincinnati recently accepted $5 million from dōTERRA, an MLM company selling essential oils based on dubious claims. This is most definitely not a good look.
Richard Jaffe was Dr. Stanislaw Burzynski’s lawyer. For nearly two decades, Jaffe defended this cancer quack from the FDA, Texas Medical Board, and the government in the name of “health freedom” and even invented Burzynski’s business model of having over 70 clinical trials open that allow him to treat any cancer patient he wants. More recently, he’s been a defender of for-profit quack stem cell clinics. Last week, he shocked me by finding one stem cell clinic so quacky that he thinks the government should shut it down, even going so far as to use criminal prosecution if necessary. Basically, he’s willing to throw one quack stem cell clinic under the bus, so that others can continue to profit.
“Right-to-try” laws are a cruel sham that purport to allow terminally ill patients access to promising experimental drugs. In reality, they strip away many protections and leave vulnerable patients on their own. After four years and a number of toothless state laws, a federal version of “right-to-try” has passed Congress and is poised to become law. Once President Trump signs the bill this week, this federal version of “right-to-try” will leave terminally ill patients on their own and will likely be the first step in returning the FDA to its pre-thalidomide state, in which it only required evidence of safety, not efficacy, to approve drugs.
